Figure 2From: The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinomaInhibition of GBC-SD cell growth in the presence of DOX (solid line) or DOX and SST (dashed line). The relative survival percentage is shown. Means that are significantly different from the control group are indicated with an asterisk (P < 0.05).Back to article page